The signal transduction mediated by erythropoietin and proinflammatory cytokines in the JAK/STAT pathway in the children with cerebral palsy.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Brain & development (Tokyo. 1979)

• Publication date

  2009-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.braindev.2008.06.011PMID 18715729
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Signal transducers and activators of transcription 5 contributes to erythropoietin-mediated neuroprotection against hippocampal neuronal death after transient global cerebral ischemia.

  2007cited by this paper
• STAT3 signaling and the hyper-IgE syndrome.

  2007cited by this paper
• Antenatal infection/inflammation and fetal tissue injury.

  2007cited by this paper
• Regulation of cytokine signaling pathways by PIAS proteins

  2006cited by this paper
• The role of Janus kinases in haemopoiesis and haematological malignancy

  2006cited by this paper
• Regional Differences in Blood-Brain Barrier Permeability Changes and Inflammation in the Apathogenic Clearance of Virus from the Central Nervous System1

  2006cited by this paper
• A gain-of-function mutation of JAK2 in myeloproliferative disorders.

  2005cited by this paper
• Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis.

  2005cited by this paper
• Negative regulation of cytokine signaling and immune responses by SOCS proteins

  2005cited by this paper
• Suppressors of cytokine signaling in health and disease

  2005cited by this paper
• Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders.

  2005cited by this paper
• Erythropoietin promotes regeneration of adult CNS neurons via Jak2/Stat3 and PI3K/AKT pathway activation.

  2005cited by this paper
• Erythropoietin and the nervous system.

  2004cited by this paper
• The erythropoietin receptor and its expression in tumor cells and other tissues.

  2004cited by this paper
• Beneficial effect of erythropoietin on experimental allergic encephalomyelitis

  2004cited by this paper
• Hypoxia-ischemia affects erythropoietin and erythropoietin receptor expression pattern in the neonatal rat brain.

  2004cited by this paper
• Coagulation, Inflammation, and the Risk of Neonatal White Matter Damage

  2004cited by this paper
• The Janus kinases (Jaks)

  2004cited by this paper
• Infectious and inflammatory mechanisms in preterm birth and cerebral palsy.

  2004cited by this paper
• The Chemoattractants, IL-8 and Formyl-Methionyl-Leucyl-Phenylalanine, Regulate Granulocyte Colony-Stimulating Factor Signaling by Inducing Suppressor of Cytokine Signaling-1 Expression1

  2004cited by this paper
• Seminar. Cerebral palsy

  2004cited by this paper
• Erythropoietin and hypoxia stimulate erythropoietin receptor and nitric oxide production by endothelial cells.

  2004cited by this paper
• Erythropoietin protects the in vitro blood–brain barrier against VEGF‐induced permeability

  2003cited by this paper
• The cellular biology of erythropoietin receptors.

  2003cited by this paper
• The 'Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling.

  2003cited by this paper
• Erythropoietin Selectively Attenuates Cytokine Production and Inflammation in Cerebral Ischemia by Targeting Neuronal Apoptosis

  2003cited by this paper
• Pleiotropic functions of erythropoietin.

  2003cited by this paper
• Identification of the human erythropoietin receptor region required for Stat1 and Stat3 activation.

  2002cited by this paper
• Members of the PIAS family act as SUMO ligases for c-Jun and p53 and repress p53 activity

  2002cited by this paper
• Immune mechanisms in the pathogenesis of cerebral palsy: implication of proinflammatory cytokines and T lymphocytes.

  2002cited by this paper
• Clinical chorioamnionitis, elevated cytokines, and brain injury in term infants.

  2002cited by this paper
• Erythropoietin exerts an anti-inflammatory effect on the CNS in a model of experimental autoimmune encephalomyelitis.

  2002cited by this paper
• The erythropoietin receptor.

  2001cited by this paper
• Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress

  2001cited by this paper
• Immunoreceptor Tyrosine-Based Inhibitory Motif of the IL-4 Receptor Associates with SH2-Containing Phosphatases and Regulates IL-4-Induced Proliferation1

  2001cited by this paper
• Erythropoietin inhibits calcium-induced neurotransmitter release from clonal neuronal cells.

  2000cited by this paper
• Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury.

  2000cited by this paper
• Neuroprotection and Angiogenesis: Dual Role of Erythropoietin in Brain Ischemia.

  2000cited by this paper
• SOCS: physiological suppressors of cytokine signaling.

  2000cited by this paper
• A putative ubiquitin ligase required for efficient mRNA export differentially affects hnRNP transport.

  2000cited by this paper
• Suppressor of cytokine signaling-3 preferentially binds to the SHP-2-binding site on the shared cytokine receptor subunit gp130.

  2000cited by this paper
• Crystallographic evidence for preformed dimers of erythropoietin receptor before ligand activation.

  1999cited by this paper
• Effects of Erythropoietin on Neuronal Activity

  1999cited by this paper
• General mechanisms of cytokine receptor signaling.

  1998cited by this paper
• Absence of cytokine receptor-dependent specificity in red blood cell differentiation in vivo.

  1998cited by this paper
• Nucleocytoplasmic transport: the last 200 nanometers.

  1998cited by this paper
• The protein tyrosine phosphatase SHP-2 negatively regulates ciliary neurotrophic factor induction of gene expression.

  1997cited by this paper
• Direct association with and dephosphorylation of Jak2 kinase by the SH2-domain-containing protein tyrosine phosphatase SHP-1

  1996cited by this paper
• A novel receptor-mediated nuclear protein import pathway.

  1996cited by this paper
• DNA binding of in vitro activated Stat1 alpha, Stat1 beta and truncated Stat1: interaction between NH2‐terminal domains stabilizes binding of two dimers to tandem DNA sites.

  1996cited by this paper
• Nucleocytoplasmic Transport

  1996cited by this paper
• The effect of growth hormone on low-density lipoprotein cholesterol and lipoprotein (a) levels in familial hypercholesterolemia.

  1996cited by this paper
• Conclusions and prospects

  1995cited by this paper
• Neurotrophic effect of hematopoietic cytokines on cholinergic and other neurons in vitro

  1995cited by this paper
• Erythropoietin Induces the Tyrosine Phosphorylation, Nuclear Translocation, and DNA Binding of STAT1 and STAT5 in Erythroid Cells (*)

  1995cited by this paper
• Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals.

  1995cited by this paper
• Regulation of JAK3 expression in human monocytes: phosphorylation in response to interleukins 2, 4, and 7

  1995cited by this paper
• Insulin stimulates the phosphorylation of Tyr538 and the catalytic activity of PTP1C, a protein tyrosine phosphatase with Src homology-2 domains.

  1994cited by this paper
• Stat3 and Stat4: members of the family of signal transducers and activators of transcription.

  1994cited by this paper
• A single phosphotyrosine residue of Stat91 required for gene activation by interferon-gamma.

  1993cited by this paper
• Cerebral Palsy Epidemiology: Where are We Now and Where are We Going?

  1992cited by this paper
• A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation

  1992cited by this paper
• The gene for the human erythropoietin receptor: analysis of the coding sequence and assignment to chromosome 19p.

  1990cited by this paper
• Cerebral Palsy

  1983cited by this paper
• [Cerebral palsy].

  1972cited by this paper

• Efficacy of Medicated Thread Moxibustion of Zhuang Medicine on Skin Lesions in Eczema Rats Based on p38/NF-κB and JAK1-STAT6 Pathways

  2025cites this paper
• Research progress on high-concentration oxygen therapy after cerebral hemorrhage

  2024cites this paper
• Mechanistic Association of Hepatoblastoma with Cerebral Palsy: A Narrative Review

  2024influential citation
• Whole genome methylation and transcriptome analyses to identify risk for cerebral palsy (CP) in extremely low gestational age neonates (ELGAN)

  2021cites this paper
• Transcriptome analysis and differentially expressed gene screening for hypoxic-ischemic brain damage in rats treated with acupuncture

  2021cites this paper
• Erythropoietin Increases GABAA Currents in Human Cortex from TLE Patients.

  2020cites this paper
• Erythropoietin attenuates propofol-induced hippocampal neuronal cell injury in developing rats by inhibiting toll-like receptor 4 expression.

  2019cites this paper
• Antiviral effects and mechanisms of Yinhuapinggan granule against H1N1 influenza virus infection in RAW264.7 cells

  2018cites this paper
• Effects of erythropoietin on spontaneous and oxytocin induced myometrial contractions in the nonpregnant rat.

  2017cites this paper
• The Neuroprotective Effect of Erythropoietin in Rat Hippocampus in an Endotoxic Shock Model.

  2016cites this paper
• The Influence of Neurodevelopmental Treatment on Transforming Growth Factor-β1 Levels and Neurological Remodeling in Children With Cerebral Palsy

  2016cites this paper
• The Role of Erythropoietin and its Receptor in the Immune , Central Nervous and Cardiovascular Systems

  2015cites this paper
• The Data-Based Mathematical Modeling and Parameter Identification in JAK-STAT Signaling Pathway by Using a Hybrid Evolutionary Algorithm

  2010cites this paper
• Does erythropoietin affect motility of spermatozoa?

  2010cites this paper
• [Tumor stem cell research - basis and challenge for diagnosis and therapy].

  2010cites this paper
• Hemorheological and cardiovascular effects of erythropoietin in a rat model of sports doping

  2010cites this paper
• Tumor-Stammzellforschung – Basis und Herausforderung für Diagnostik und Therapie

  2010cites this paper
• Erythropoietin Promotes Deleterious Cardiovascular Effects and Mortality Risk in a Rat Model of Chronic Sports Doping

  2009cites this paper
• Erythropoietin Promotes Deleterious Cardiovascular Effects and Mortality Risk in a Rat Model of Chronic Sports Doping

  2009cites this paper